Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

54.92%

64.90%

56.27%

66.15%

Annual Dental Visits (ADV) Total

0.39%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

41.66%

46.74%

31.08%

48.16%

Appropriate Testing for Pharyngitis (CWP)

76.73%

77.56%

86.06%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

90.09%

93.08%

88.06%

91.27%

Asthma Medication Ratio (AMR) Total

72.94%

69.41%

73.55%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

64.06%

66.19%

59.86%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

41.85%

68.61%

47.45%

71.78%

Breast Cancer Screening (BCS)

41.23%

55.25%

Breast Cancer Screening (BCS-E)

41.03%

54.94%

41.81%

56.66%

Cervical Cancer Screening (CCS)

41.85%

59.85%

39.68%

60.10%

Childhood Immunization Status (CIS) Combination #10

23.11%

35.04%

31.14%

31.32%

Chlamydia Screening in Women (CHL) Total

55.18%

61.07%

55.47%

61.46%

Controlling High Blood Pressure (CBP)

36.01%

65.45%

35.77%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

77.94%

80.86%

79.67%

83.51%

Eye Exam for Patients With Diabetes (EED)

31.14%

56.20%

45.01%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

22.26%

27.73%

26.85%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

35.46%

46.35%

34.91%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

22.21%

41.03%

33.93%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

50.34%

37.31%

46.55%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

54.84%

57.90%

53.57%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

53.57%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

35.28%

55.72%

40.39%

59.64%

Immunizations for Adolescents (IMA) Combination #2

21.41%

38.93%

26.76%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

22.69%

16.94%

23.99%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

32.13%

38.80%

34.22%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

39.62%

39.01%

40.12%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

40.12%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

42.81%

31.93%

26.29%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

77.62%

75.79%

78.08%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

83.43%

86.96%

85.13%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

87.82%

≤ 92.72%

135.60%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

63.50%

86.86%

68.86%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

60.10%

80.78%

68.37%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

13.91%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

13.91%

25.81%

22.09%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

6.90%

≤ 2.45%

NQ

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

80.87%

81.64%

81.64%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

80.71%

73.63%

56.44%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

63.10%

67.07%

66.17%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

75.92%

70.37%

53.23%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

55.56%

63.89%

66.67%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

65.86%

75.44%

61.14%

72.74%

Use of Opioids at High Dosage (HDO)

7.29%

≤ 2.19%

3.82%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.81%

≤ 0.87%

2.90%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

52.07%

83.21%

65.45%

86.20%